ArticleFrontiers in clinical diabetes and healthcare2026
Quantitative and preliminary clinical assessment of glycohypoxia as an oxygen-unloading defect linking chronic hyperglycemia to low-grade tissue hypoxia in type 2 diabetes: a targeted translational meta-regression with exploratory blood-sample validation.
Article in Frontiers in clinical diabetes and healthcare, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic hyperglycemia may impair tissue oxygen delivery by glycating hemoglobin, increasing oxygen affinity, shifting the oxyhemoglobin dissociation curve leftward, and reducing oxygen unloading, a state termed glycohypoxia. This study quantified HbA1c-dependent oxygen-release impairment and tested whether the modeled signal is supported by preliminary clinical validation in type 2 diabetes mellitus (T2DM). Methods: Six human studies (1984-2012; N = 450) reporting HbA1c and oxygen-release metrics were synthesized using random-effects meta-regression. The pooled ΔP50 was translated into oxygen-unloading changes using the Hill equation across microvascular PO Results: Sensitivity-adjusted meta-regression showed ΔP50 = -0.19 mmHg per 1% HbA1c (95% CI: -0.26 to -0.11; P < 0.001; I2 = 45%), predicting 0.5-1.3% less oxygen unloading per 1% HbA1c and 1.5-3.9% cumulatively from HbA1c 6-9%. Clinically, higher HbA1c was associated with lower P50 (27.0 ± 0.5 to 26.2 ± 0.7 mmHg; P < 0.01), reduced 2,3-BPG (4.8 ± 0.4 to 4.2 ± 0.5 µmol/g Hb), increased SpO Conclusions: Quantitative modeling and exploratory clinical validation converged to support glycohypoxia as a measurable oxygen-handling phenotype in T2DM. This pattern may indicate a chronic low-grade functional hypoxic burden that accumulates with glycemic exposure and contributes to T2DM diabetic complications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.